Company Search:
Advanced Search
Sponsored Links
Novartis AG Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other pharmaceutical manufacturers in Europe: Bayer AG of Germany (2017 sales of 35.02 billion Euro [US$43.02 billion] of which 48% was Pharmaceuticals & Biological Products), Sanofi S.A. of France (36.20 billion Euro [US$44.48 billion] of which 83% was Pharmaceuticals), and Roche Holding Aktiengesellschaft (53.30 billion Swiss Francs [US$56.28 billion] of which 77% was Pharmaceuticals).

Sales Analysis. Novartis reported sales of 49.16 billion Swiss Francs (US$51.91 billion) for the year ending December of 2017. This represents a very small increase of 0.7% versus 2016, when the company's sales were 48.83 billion Swiss Francs. The sales level in 2017 was fairly close to the level five years ago: in 2012, Novartis had sales of 52.86 billion Swiss Francs. Sales of Alcon saw an increase that was more than double the company's growth rate: sales were up 2.8% in 2017, from 5.75 billion Swiss Francs to 5.91 billion Swiss Francs. Not all segments of Novartis experienced an increase in sales in 2017: sales of Sandoz fell 1.7% to 9.86 billion Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novartis AG
  Stock Performance Chart for Novartis AG
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 78.00
(Figures in Swiss Francs)
1 Week -0.5%   13 Weeks -3.5%  
4 Weeks -6.9%   52 Weeks 3.2%  
Novartis AG Key Data:
  Ticker: NOVN Country: Switzerland
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 49,155,863,450
(Year Ending Jan 2018).
Employees: 121,597
  Currency: Swiss Francs Market Cap: 180,761,606,922
  Fiscal Yr Ends: December Shares Outstanding: 2,317,456,499
  Share Type: Namenaktie Closely Held Shares: 88,340,769
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.